| Log in

Rakesh Jhunjhunwala-backed Concord Biotech looking to enter biosimilars market

30 May, 2014

Ahmedabad-based bulk drug maker Concord Biotech Ltd is in talks with strategic players for a partnership to enter into the biosimilars market, a top executive of the company told V ....

To read the Full Story

Definitive news, exclusives, analyses and videos

  • Exclusive reporting, expert analysis and commentary on PE/VC/M&A deals & dealmakers
  • Daily, weekly and monthly curated newsletters on the deal ecosystem in India
  • Breaking news alerts
  • Participation in marquee events at concessional rates

Comprehensive | Accurate | Unbiased | Impeccably sourced


Leave Your Comment
Lupin inks Japanese biosimilars joint venture with Yoshindo

Lupin inks Japanese biosimilars joint venture with Yoshindo

Jasleen Kaur Batra 4 years ago
Mumbai-based pharma major Lupin Limited has entered into a strategic joint...
Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Company watch: Concord Biotech eyes new opportunities after Quadria’s backing

Jyotindra Dubey 3 months ago
Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20...
Theramyt Novobiologics investing $10M by 2015 to develop IP platform

Theramyt Novobiologics investing $10M by 2015 to develop IP platform

Lohit Jagwani 4 years ago
Bangalore-based Theramyt Novobiologics Pvt Ltd, which recently raised its first...
No Comments

Rakesh Jhunjhunwala-backed Concord Biotech looking to enter biosimilars market

Powered by WordPress.com VIP